Please assess the completion status of the following clinical trial:

Trial Title: Repetitive Transcranial Magnetic Stimulation for Voices

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
PROTOCOL ENTRY CRITERIA:~Inclusion criteria:~* Diagnosis of schizophrenia or schizoaffective disorder based on DSM-IV version of SCID~* Auditory hallucinations of spoken speech occurring at least 5 times per day where subject able to discern verbal content~* Right-handed~* At least 4 weeks on stable antipsychotic medication~Exclusion criteria:~* history of seizure (unless due to drug withdrawal or medication that is no longer prescribed)~* history of epilepsy in first degree relatives~* estimated IQ less than 80~* unable to provide informed consent~* significant unstable medical condition~* current treatment with clozapine or bupropion~* cochlear implants or other metal in the head (surgical, etc.)~* history of cardiac arrhythmia~* cardiac pacemaker~* active drug or alcohol abuse within prior 6 weeks~* pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- active rTMS (Type: EXPERIMENTAL): 1-Hz rTMS delivered to left temporoparietal cortex at 90% motor threshold for 16 minutes per session given one session per day for nine consecutive days (with the exception of weekends)
- sham stimulation (Type: PLACEBO_COMPARATOR): Sham stimulation delivered 16 minutes per session given one session per day for nine consecutive days (with the exception of weekends)

Based on this trial design, predict the completion outcome and termination type (if applicable).